Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF

+ Add to Watchlist

1621:JP

20,320.0000 JPY 80.0000 0.39%

As of 01:50:43 ET on 04/17/2015.

Snapshot for Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF (1621)

Open: 20,400.0000 High - Low: 20,440.0000 - 20,210.0000 Primary Exchange: Tokyo
Volume: 461 52-Week Range: 14,100.0000 - 22,000.0000 Beta vs TP17PHRM: 0.9512

ETF Chart for 1621

No chart data available.
  • 1621:JP 20,320.0000
  • 1D
  • 1M
  • 1Y
20,400.0000
Interactive 1621 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1621

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated in Japan. The objective of the Fund is to provide investment results that correspond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-03-25 Telephone: 81-3-3241-9511
Managers: -
Web Site: www.nomura-am.co.jp

Fundamentals for 1621

NAV (on 2015-04-17) 20,207.9000
Assets (M) (on 2015-04-17) 839.0000
Shares out (M) 0.04
Market Cap (M) 844.09
% Premium 0.55
Average 52-Week % Premium 0.0278
Fund Leveraged N

Dividends for 1621

Dividend Type Distribution
Dividend Frequency Annual
Last Dividend Net (on 2014-07-11) 1,067.0000
Dividend Yield (ttm) 5.25%

Performance for 1621

1-Month +1.09% 1-Year +52.34%
3-Month +20.67% 3-Year +31.57%
Year To Date +23.53% 5-Year +17.01%
Expense Ratio 0.32

Top Fund Holdings for 1621

Filing Date: 03/31/2015
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 28,800 172,771,200 20.444%
Astellas Pharma Inc 87,600 172,353,000 20.394%
Eisai Co Ltd 10,100 86,203,500 10.200%
Otsuka Holdings Co Ltd 15,300 57,520,350 6.806%
Daiichi Sankyo Co Ltd 25,900 49,391,300 5.844%
Shionogi & Co Ltd 12,000 48,060,000 5.687%
Ono Pharmaceutical Co Ltd 3,500 47,530,000 5.624%
Chugai Pharmaceutical Co Ltd 7,700 29,144,500 3.449%
Santen Pharmaceutical Co Ltd 14,100 24,675,000 2.920%
Mitsubishi Tanabe Pharma Corp 9,000 18,558,000 2.196%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil